Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
Enterprise posts CF win, succeeding where Big Pharma stumbled
The phase 2 trial hit its primary endpoint, furthering the biotech’s pursuit of a target that companies including Vertex have worked on previously.
Nick Paul Taylor
May 12, 2026 4:00am
BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed
May 12, 2026 1:56am
Fierce Pharma
Daiichi Sankyo targets global top 5 oncology rank by 2035
May 11, 2026 10:22am
Inhibrx’s OX40-Keytruda combo shows promise in early ph. 2 data
May 11, 2026 10:06am
Novo salvages happy ending for scrapped Parkinson’s therapy
May 11, 2026 8:30am
Fierce Pharma
Trump plans to end stormy 14-month tenure of FDA chief Makary
May 8, 2026 3:38pm
